GT Biopharma, Inc. (GTBP) stock
GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.18−0.35 (-10.04%)
Close on Nov 17, 2026Market cap $143.45MP/E –Yield –
GT Biopharma gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2015 it was 100.0%, against 6.6% the year before. The highest annual figure on record is 100.0% in fiscal 2015.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | 100.0% | +93.4 |
| FY2014 | Dec 31, 2014 | 6.6% | −32.0 |
| FY2013 | Dec 31, 2013 | 38.6% | −33.9 |
| FY2012 | Dec 31, 2012 | 72.5% | +157.1 |
| FY2011 | Dec 31, 2011 | -84.6% | +406.3 |
| FY2010 | Dec 31, 2010 | -490.9% | – |
See a number that looks wrong?